Pipeline

Our pipelines embody our dedication to groundbreaking healthcare advancements. Focused on pivotal areas in disease management, our projects aim to significantly improve patient outcomes. Here, we present a vision of the future in medical innovation, catering to the needs of patients, physicians, oncologists, and administrators.

Pipelines

1. Pancreatic Cancer Early Detection: Targeting the Silent Killer

Our pancreatic cancer project has made significant strides in identifying this challenging disease in its early stages. Following substantial progress in development, we are now actively engaged in validating our clinical results. Leveraging cutting-edge biomarkers and AI technology, we are gearing up to initiate clinical trials at two selected sites.

2. Multi Cancer Early Detection: Early Intervention Screening

We have successfully completed the planning of a major international multi cancer study involving several thousand participants. Currently, the first thousand samples are analyzed using multi-omics biomarkers and AI. The next phase involves a blinded validation study with around thousand participants. Clinical partners are welcome.

3. Cancer Monitoring: Continous Care, Enhanced Outcomes

Our cancer monitoring project is dedicated to providing ongoing surveillance for patients in remission or undergoing treatment. This vigilant approach ensures timely detection of recurrence or progression, enabling prompt intervention. Currently we are planning the studies and developing the technology to monitor cancer patients. A first pilot study is ongoing and further validation is planned.

4. Therapy Response Prediction: Personalized Medicine for Tailored Therapies

This project is at the cutting edge of precision medicine, using predictive models to determine individual responses to various cancer treatments. This helps in customizing patient care for maximum efficacy and minimal side effects. Wholomics is currently in the planning phase of this study but is allready conducting a pilot study on multiple hundred patients.

5. Therapy Response Prediction: Proactive Approach to Neuro Health

Early detection is crucial in managing neuro-degenerative diseases. Our project focuses on identifying early markers of conditions like Alzheimer's and Parkinson's, offering hope for earlier intervention and better management strategies. Wholomics is currently looking for partners in the area of neurodegenerative diseases.

Become a Partner

If you would like to partner with us, fill out the form below and one of our staff members will get back to you.